Posted on 27-12-16
Curegarden launches a natural pain relieving balm which not only relieves pain but also stops joints from further degradation.
Curegarden has used Boswellia Serrata, in the formulation along with the essential oil of Boswellia. Boswellia is a tree gum resin that has multiple health benefits. Also known as Indian frankincense, it has been burned as incense in religious and cultural ceremonies for centuries. Boswellia is widely regarded as a potent anti-inflammatory nutrient, wherein its primary active ingredient, acetyl-11-keto-β-boswellic acid (AKBA), inhibits the inflammatory enzyme 5-lipoxygenase.
Rhulief balm contains the potent extract of the botanic Boswellia Serrata, blended with the essential oil of Boswellia to relieve pain and inflammation to prevent further joint damage. Boswellia, with its unique lipo oxygenase (LOX) inhibitory action, not only relieves pain, but arrests underlying inflammation to protect the joint from further damage.
What sets this balm apart from all the other balms in the market are two unique properties of boswellia; it stop further degradation of joints due to its anti-inflammatory properties and unlike all the NSAID’s in the market, Rhulief works on both pain pathways(COX,LOX), so it stops pain and relieves inflammation. The balm is all set to launch next month in Bangalore, it will be available online across India.
Curegarden represents a dream. A dream of sharing a happier, healthier body and quality of life with the use of nature's best ingredients. Botanics, when extracted for their bioactive compounds, offer a most effective approach to improving well-being and quality of life. It is based on the belief that botanicals of the highest quality would have a positive effect — without any negative side effects — on people's health. Over the years,we have seen and experienced personally the wonderful benefits of these high quality botanical products and are delighted to share them with others.
Arjuna Natural Extracts Ltd is India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries for over two decades. With customers in around 40 countries, the company has close to 50 patents to its credit of which majority are commercialized globally. The company has R&D tie ups with international universities from Australia, US and Japan. The highly advanced R&D unit at Arjuna is a complete research facility for phytochemistry, pharmacokinetics, formulation and development, pre-clinical and clinical studies.
FIND US ON FACEBOOK